Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies

被引:0
作者
Patricia Pozo-Rosich
David W. Dodick
Anders Ettrup
Joe Hirman
Roger Cady
机构
[1] Headache Unit,Neurology Department
[2] Vall d’Hebron,Headache and Neurological Pain Research Group, Department de Medicina
[3] University Hospital and Research Institute,undefined
[4] Universitat Autonoma de Barcelona,undefined
[5] Vall d’Hebron,undefined
[6] University Hospital and Research Institute,undefined
[7] Universitat Autonoma de Barcelona,undefined
[8] Mayo Clinic,undefined
[9] Atria Institute,undefined
[10] H. Lundbeck A/S,undefined
[11] Pacific Northwest Statistical Consulting,undefined
[12] Inc.,undefined
[13] Lundbeck LLC,undefined
[14] RK Consults,undefined
[15] Missouri State University,undefined
来源
BMC Neurology | / 22卷
关键词
Migraine; Prevention; Efficacy; Eptinezumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 94 条
[1]  
Bigal ME(2008)Clinical course in migraine: conceptualizing migraine transformation Neurol 71 848-855
[2]  
Lipton RB(2017)Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design J Headache Pain 18 101-2356
[3]  
Serrano D(2020)Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) study Headache 60 2340-1299
[4]  
Lipton RB(2019)Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CaMEO) study Headache 59 1286-113
[5]  
Scher AI(2020)Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study J Headache Pain 21 23-315
[6]  
Buse DC(2017)When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month Cephalalgia 37 104-1592
[7]  
Reed ML(2011)Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS) Cephalalgia 31 301-59
[8]  
Fanning KM(2018)Health care resource utilization and migraine disability along the migraine continuum among patients treated for migraine Headache 58 1579-1039
[9]  
Buse DC(2012)Canadian headache society guideline for migraine prophylaxis Can J Neurol Sci 39 S1-989
[10]  
Fanning KM(2021)The American headache society consensus statement: update on integrating new migraine treatments into clinical practice Headache 61 1021-1085